APA (7th ed.) Citation

Myklebust, H., Grønnestad, E., Peel, G., Flemmen, H. Ø., Brekke, K., Broch, L., . . . Fee, D. B. (2026). The Norwegian NBSS‐SF: Psychometric Properties in People With Multiple Sclerosis Treated With Natalizumab. Acta Neurologica Scandinavica, 2026, 1. https://doi.org/10.1155/ane/7868813

Chicago Style (17th ed.) Citation

Myklebust, Harald, et al. "The Norwegian NBSS‐SF: Psychometric Properties in People With Multiple Sclerosis Treated With Natalizumab." Acta Neurologica Scandinavica 2026 (2026): 1. https://doi.org/10.1155/ane/7868813.

MLA (9th ed.) Citation

Myklebust, Harald, et al. "The Norwegian NBSS‐SF: Psychometric Properties in People With Multiple Sclerosis Treated With Natalizumab." Acta Neurologica Scandinavica, vol. 2026, 2026, p. 1, https://doi.org/10.1155/ane/7868813.